| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Life Sciences Tools & Services (Health Care sector), MYGN's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.07M | $4.20M | - | |
| COO | 629.6K | $3.09M | - | |
| Other | 573.4K | $2.26M | - | |
| VP | 351.2K | - | - | |
| Dir | 341.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Kumar Rashmi | Director | Sell | 15,000 | $4.46 | $66,843.00 | -8.0% | - | - | |
| May 14, 2026 | Bisaro Paul | Director | Buy | 7,500 | $3.69 | $27,637.50 | +8.3% | - | - | |
| Mar 9, 2026 | Raha Samraat S. | President And CEO | Buy | 40,000 | $5.00 | $199,844.00 | +8.8% | - | - | |
| Feb 27, 2026 | Phanstiel S. Louise62 | Director | Buy | 104,507 | $4.73 | $494,722.42 | +58.9% | - | - | |
| Oct 11, 2024 | Diaz Paul J74 | President And CEO | Sell | 15,000 | $22.93 | $343,950.00 | -1.5% | -38.4% | -68.9% | |
| Sep 11, 2024 | Diaz Paul J74 | President And CEO | Sell | 15,000 | $26.72 | $400,800.00 | -1.5% | -41.6% | -70.8% | |
| Sep 11, 2024 | Muzzey Dale | Chief Scientific Officer | Sell | 2,100 | $26.17 | $54,961.20 | -1.9% | -41.6% | -70.8% | |
| Sep 9, 2024 | Dreismann Heinrich | Director | Sell | 10,000 | $27.05 | $270,520.00 | -7.6% | -45.2% | -74.3% | |
| Sep 3, 2024 | Reitan Colleen F69 | Director | Sell | 46,012 | $27.95 | $1,285,851.35 | -52.0% | -39.2% | -75.2% | |
| Aug 21, 2024 | Ancona Margaret | SVP, Chief Of Staff | Sell | 11,538 | $27.82 | $320,987.16 | -12.7% | -46.3% | -79.1% |